Categories
Change Password!
Reset Password!
A study was conducted to find the association between allopurinol use and incidence of type-2 diabetes.
From a recent study, it
was concluded that the allopurinol use was not related to the reduced incidence
of type 2 diabetes in gout patients. The incidence of diabetes is not found to
be related to baseline serum urate or variation in serum urate level.
A study was conducted to
find the association between allopurinol use and incidence of type-2 diabetes.
In this study, patients
were divided into subgroups based on more than 30 continuous days of
allopurinol administered, versus no allopurinol. Six hundred and six, gout patients used
allopurinol for more than 30 days continuously and 478 patients never used the
allopurinol.
After an average 7.9 ± 4.8 years of follow-up, no considerable variation in the diabetes incidence between the two groups was observed.
There is no correlation
between allopurinol use and the reduced incidence of type 2 diabetes in gout
patients.
Medicine
Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study
Anastasia Slobodnick et al.
Comments (0)